Immune privilege of endothelial cells differentiated from endothelial progenitor cells

Cardiovascular Research

Volumn 88, Issue 1, 2010, Pages 121-129

  Ladhoff, Juliane ^a   Fleischer, Bernhard ^a   Hara, Yoshiaki ^a   Volk, Hans Dieter ^a   Seifert, Martina ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cell differentiation; Endothelial function; Immunology; Tissue engineering; Transplantation

Indexed keywords

ALLOANTIBODY; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; AORTA; ARTICLE; BLOOD VESSEL GRAFT; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; STEM CELL; UPREGULATION; VASCULAR SURGERY;

ANIMALS; AORTA; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COMPLEMENT ACTIVATION; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIAL CELLS; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTERFERON-GAMMA; MALE; PHENOTYPE; RATS; RATS, INBRED WF; RATS, INBRED WKY; STEM CELL TRANSPLANTATION; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956866684     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq109     Document Type: Article

References (36)

1. Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
2. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
3. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005;112:1618-1627.
4. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endo-thelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
5. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77.
6. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752-2760.
7. Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008;111: 1302-1305.
8. Shepherd BR, Enis DR, Wang F, Suarez Y, Pober JS, Schechner JS. Vascularization and engraftment of a human skin substitute using circulating progenitor cell-derived endo-thelial cells. FASEB J 2006;20:1739-1741.
9. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-1809.
10. Pompilio G, Steinhoff G, Liebold A, Pesce M, Alamanni F, Capogrossi MC et al. Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results. Thorac Cardiovasc Surg 2008;56:71-76.
11. Sreerekha PR, Krishnan LK. Cultivation of endothelial progenitor cells on fibrin matrix and layering on dacron/polytetrafluoroethylene vascular grafts. Artif Organs 2006;30: 242-249.
12. Shirota T, Yasui H, Matsuda T. Intralumenal tissue-engineered therapeutic stent using endothelial progenitor cell-inoculated hybrid tissue and in vitro performance. Tissue Eng 2003;9:473-485.
13. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001;7:1035-1040.
14. Aoki J, Serruys PW, Van Beusekom H, Ong AT, McFadden EP, Sianos G et al. Endo-thelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 2005;45:1574-1579.
15. Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003;108: 2710-2715.
16. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003;93:e17-e24.
17. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascu-larization. Proc Natl Acad Sci USA 2000;97:3422-3427.
18. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004;114:330-338.
19. Nicosia RF, Villaschi S, Smith M. Isolation and characterization of vasoformative endo-thelial cells from the rat aorta. In Vitro Cell Dev Biol Anim 1994;30A:394-399.
20. Zdoroveac A, Doebis C, Laube H, Brosel S, Schmitt-Knosalla I, Volk HD et al. Modulation of graft arteriosclerosis in a rat carotid transplantation model. J Surg Res 2008; 145:161-169.
21. Kasimir MT, Rieder E, Seebacher G, Silberhumer G, Wolner E, Weigel G et al. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs 2003;26:421-427.
22. Doebis C, Schu S, Ladhoff J, Busch A, Beyer F, Reiser J et al. An anti-major histocom-patibility complex class I intrabody protects endothelial cells from an attack by immune mediators. Cardiovasc Res 2006;72:331-338.
23. Gui L, Muto A, Chan SA, Breuer CK, Niklason LE. Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng Part A 2009; 15:2665-2676.
24. Zhang SJ, Zhang H, Wei YJ, Su WJ, Liao ZK, Hou M et al. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res 2006;16:577-584.
25. Bellik L, Ledda F, Parenti A. Morphological and phenotypical characterization of human endothelial progenitor cells in an early stage of differentiation. FEBS Lett 2005;579:2731-2736.
26. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003;93:1023-1025.
27. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculo-genesis. Arterioscler Thromb Vasc Biol 2004;24:288-293.
28. Neumuller J, Neumuller-Guber SE, Lipovac M, Mosgoeller W, Vetterlein M, Pavelka M et al. Immunological and ultrastructural characterization of endothelial cell cultures differentiated from human cord blood derived endothelial progenitor cells. Histochem Cell Biol 2006;126:649-664.
29. Yun S, Rose ML, Fabre JW. The induction of major histocompatibility complex class II expression is sufficient for the direct activation of human CD4+ T cells by porcine vascular endothelial cells. Transplantation 2000;69:940-944.
30. Sims TN, Afrouzian M, Urmson J, Zhu LF, Halloran PF. The role of the class II trans-activator (CIITA) in MHC class I and II regulation and graft rejection in kidney. Am J Transplant 2001;1:211-221.
31. Dye JF, Jablenska R, Donnelly JL, Lawrence L, Leach L, Clark P et al. Phenotype of the endothelium in the human term placenta. Placenta 2001;22:32-43.
32. Pietra BA, Wiseman A, Bolwerk A, Rizeq M, Gill RG. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000;106: 1003-1010.
33. Suarez Y, Shepherd BR, Rao DA, Pober JS. Alloimmunity to human endothelial cells derived from cord blood progenitors. J Immunol 2007;179:7488-7496.
34. Kreisel D, Krupnick AS, Gelman AE, Engels FH, Popma SH, Krasinskas AM et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med 2002;8:233-239.
35. Bian H, Reed EF. Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha. J Immunol 1999;163:1010-1018.
36. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004;109:1769-1775.